Skip to main content
OpenTrials
Completed

NCT Number: NCT06463288

Comparison of Jacobson Relaxation Technique and Pranayama Technique in Patients With COPD

Comparison of Jacobson Relaxation Technique and Pranayama Technique in patients with COPD

Completed

Looking for future studies?

Notify Me

Key information

Conditions

COPD Chronic Disease Cough Disease Attributes Dyspnea Lung Diseases Lung Diseases, Obstructive Pathologic Processes Pathological Conditions, Signs and Symptoms Pulmonary Disease, Chronic Obstructive Quality of Life Respiration Disorders Respiratory Tract Diseases Shortness of Breath Signs and Symptoms Signs and Symptoms, Respiratory

Age range

40 year–70 year

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

Gulab Devi Chest Hospital

Lahore, Punjab Province, 54000, Pakistan

About this study

Chronic obstructive pulmonary disease is a chronic inflammatory lung disease that cause obstructed airflow from the lungs. Symptoms include Breathing difficulty. cough, mucus production and wheezing. Its typically caused by long term exposure to irritating gasses or particulate matter, most often from cigarette smoker. in this study we compare the effect of Jacobson relaxation technique and Pranayama technique on the SOB, Cough, sputum and quality of life in COPD patients.

Data were collected from Gulab Devi Chest Hospital, General Hospital, Jinnah Hospital and Mayo Hospital Lahore. Data were collected by the lottery method. Borg dyspnea scale, Spirometry, CASA-Q and Quality of life questionnaire were used before and after the intervention. Treatment was continuous 4 weeks, 3 times in a week for 15 mint. Assessment was done through the tool before and after the treatment.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • • Patients of Age between 40 and 70.
  • Both Genders (Male, Female) were included.
  • Stage 2 patient with COPD with Dyspnea FEV1 <70% and Maximal Expiratory Pressure = 50% (Gold Criteria) were included.
  • Cognitive Stable patients were included.
  • Those Patients were included who were clinically stable without exacerbations in the past 01 month.

Exclusion criteria

  • • Common Cough
  • Upper respiratory tract inflammation
  • Patients who have other co-morbid diseases which prevents them from exercise training, for example, disability due to neurological, orthopedic and acute cardiac causes
  • Patients who were mentally and physically and sick to join at the hospital or research site for training
  • Patients who were already participated or completed or in a P.R program in the past one year.

Treatment and study plan

Jacobsons Breathing Technique

Procedure

Quality of life, cough and sputum analysis, spirometry, and shortness of breath were assessed.

Pranayama Technique

Procedure

Quality of life, cough and sputum analysis, spirometry, and shortness of breath were assessed.

Primary outcomes

  1. Dyspnea Severity (Borg Scale)

    Time frame: 4 weeks

    The Borg scale measures the severity of dyspnea (shortness of breath).

    Scale Details:

    Full Title: Borg Rating of Perceived Exertion (RPE) ScaleFull Title: Borg Rating of Perceived Exertion (RPE) Scale Minimum Value: 0 (No breathlessness at all) Maximum Value: 10 (Maximal breathlessness) Interpretation: Higher scores indicate worse outcomes, meaning greater severity of dyspnea.

  2. Cough and Sputum Analysis (CASA-Q)

    Time frame: 4 Weeks

    The CASA-Q (Cough and Sputum Assessment Questionnaire) evaluates the severity and impact of cough and sputum production.

    Scale Details:

    Full Title: Cough and Sputum Assessment Questionnaire (CASA-Q) Minimum Value: 0 (No symptoms) Maximum Value: 100 (Severe symptoms) Interpretation: Higher scores indicate worse outcomes, meaning more severe symptoms of cough and sputum.

  3. Spirometry (FEV1 and FVC)

    Time frame: 4 Weeks

    Spirometry will be used to measure lung function, specifically Forced Expiratory Volume in 1 second (FEV1) and Forced Vital Capacity (FVC).

    Scale Details:

    Full Title: Spirometry (FEV1 and FVC) Minimum Value: Variable (dependent on patient's lung function) Maximum Value: Variable (dependent on patient's lung function) Interpretation: Higher values typically indicate better lung function.

Secondary outcomes

  1. Quality of Life (SF-36 Questionnaire)

    Time frame: 4 Weeks

    The SF-36 (Short Form Health Survey) questionnaire assesses the overall quality of life.

    Scale Details:

    Full Title: SF-36 Health Survey Minimum Value: 0 (Worst possible health state) Maximum Value: 100 (Best possible health state) Interpretation: Higher scores indicate better quality of life.

  2. Patient Satisfaction (Patient Satisfaction Questionnaire)

    Time frame: 4 Weeks

    The Patient Satisfaction Questionnaire measures the satisfaction of patients with the treatment they received.

    Full Title: Patient Satisfaction Questionnaire (PSQ) Minimum Value: 1 (Very dissatisfied) Maximum Value: 5 (Very satisfied) Interpretation: Higher scores indicate greater satisfaction.

Sponsors and collaborators

Lead sponsor

Riphah International University

Other

Registry information

Important dates

Study start
2023
Primary completion
2023
Study completion
2023
First posted
Jun 17, 2024
Registry last updated
Jun 17, 2024

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Related clinical trials

Published trials that share one or more normalized conditions with this study.